Our results from qMSP and bisulfite sequencing cannot confirm PLCE1 as a target for this type of epigenetic silencing, and despite high frequency of methylation in colon cancer cell lines, methylation in the PLCD1 promoter can only explain reduced expression in a subgroup of the carcinomas. The gene discussed is PLCD1; the disease is malignant colon neoplasm.